What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?

I Ahrens
, Gregory Lip
, K Peter

Research output: Contribution to journal › Editorial

67 Citations (Scopus)

Original language	English
Pages (from-to)	574-578
Number of pages	5
Journal	Thrombosis and Haemostasis
Volume	105
Issue number	4
DOIs	https://doi.org/10.1160/TH10-12-0808
Publication status	Published - 1 Apr 2011

Access to Document

10.1160/TH10-12-0808

Cite this

@article{8c6b79f719fc4a4d914df345fbc9d7fd,

title = "What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?",

author = "I Ahrens and Gregory Lip and K Peter",

year = "2011",

month = apr,

day = "1",

doi = "10.1160/TH10-12-0808",

language = "English",

volume = "105",

pages = "574--578",

journal = "Thrombosis and Haemostasis",

publisher = "Schattauer",

number = "4",

}

TY - JOUR

T1 - What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?

AU - Ahrens, I

AU - Lip, Gregory

AU - Peter, K

PY - 2011/4/1

Y1 - 2011/4/1

U2 - 10.1160/TH10-12-0808

DO - 10.1160/TH10-12-0808

M3 - Editorial

C2 - 21225102

VL - 105

SP - 574

EP - 578

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

IS - 4

ER -